AIM ImmunoTech Inc (AIM)
0.4068
0.00 (0.00%)
USD |
NYAM |
May 03, 14:53
AIM ImmunoTech Accounts Payable (Quarterly): 6.443M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.443M |
September 30, 2023 | 2.788M |
June 30, 2023 | 2.151M |
March 31, 2023 | 0.963M |
December 31, 2022 | 0.377M |
September 30, 2022 | 0.957M |
June 30, 2022 | 0.712M |
March 31, 2022 | 0.378M |
December 31, 2021 | 0.198M |
September 30, 2021 | 0.369M |
June 30, 2021 | 0.451M |
March 31, 2021 | 0.189M |
December 31, 2020 | 0.383M |
September 30, 2020 | 0.205M |
June 30, 2020 | 0.255M |
March 31, 2020 | 0.165M |
December 31, 2019 | 0.472M |
September 30, 2019 | 0.62M |
June 30, 2019 | 0.672M |
March 31, 2019 | 0.768M |
December 31, 2018 | 0.68M |
September 30, 2018 | 0.791M |
June 30, 2018 | 0.689M |
March 31, 2018 | 0.85M |
December 31, 2017 | 0.741M |
Date | Value |
---|---|
September 30, 2017 | 0.46M |
June 30, 2017 | 0.972M |
March 31, 2017 | 0.927M |
December 31, 2016 | 0.887M |
September 30, 2016 | 1.011M |
June 30, 2016 | 1.391M |
March 31, 2016 | 1.395M |
December 31, 2015 | 1.213M |
September 30, 2015 | 1.506M |
June 30, 2015 | 1.598M |
March 31, 2015 | 2.317M |
December 31, 2014 | 2.081M |
September 30, 2014 | 2.447M |
June 30, 2014 | 1.471M |
March 31, 2014 | 1.217M |
December 31, 2013 | 1.271M |
September 30, 2013 | 1.723M |
June 30, 2013 | 0.967M |
March 31, 2013 | 1.665M |
December 31, 2012 | 2.157M |
September 30, 2012 | 2.344M |
June 30, 2012 | 1.805M |
March 31, 2012 | 2.456M |
December 31, 2011 | 1.681M |
September 30, 2011 | 1.576M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.165M
Minimum
Mar 2020
6.443M
Maximum
Dec 2023
0.9867M
Average
0.451M
Median
Jun 2021
Accounts Payable (Quarterly) Benchmarks
Perspective Therapeutics Inc | 6.107M |
Protalix BioTherapeutics Inc | 4.32M |
Electromed Inc | 1.041M |
Xtant Medical Holdings Inc | 7.054M |
Armata Pharmaceuticals Inc | 1.585M |